首页> 美国卫生研究院文献>Global Pediatric Health >The Impact of Multiple Risk Factors for Venous Thromboembolism and Its Implications for Management
【2h】

The Impact of Multiple Risk Factors for Venous Thromboembolism and Its Implications for Management

机译:静脉血栓栓塞的多种危险因素的影响及其对管理的启示

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Venous thromboembolism (VTE) is a rare multifactorial disorder in childhood with an annual incidence of about 0.07 to 0.14 per 10 000 children. A 15-year-old female with a body mass index of 48 kg/m2 who endorsed oral contraceptive use presented with clinical findings consistent with deep venous thrombosis along with the presence of a pulmonary embolism. Further workup revealed that the patient was heterozygous for factor V Leiden and homozygous for prothrombin G20210A mutations. There are no current pediatric guidelines for the antithrombotic management of patients with multiple risk factors for VTE. Two such risk factors, obesity and the use of estrogen-containing hormone contraceptives, have been implicated in adult VTE cases but have not been clearly delineated in pediatric patients. The need for guidance regarding the VTE management of these patients has become more apparent given the increasing incidence of childhood obesity and the number of adolescents using oral contraceptives. Additionally, thrombophilia testing remains controversial though testing may be indicated in asymptomatic first-degree relatives and in families with antithrombin, protein C, or protein S deficiencies. Given the increased incidence of multiple risk factors for VTE, there is also a need to develop a comprehensive risk assessment tool for pediatric patients at high risk of VTE.
机译:静脉血栓栓塞症(VTE)是儿童时期罕见的多因素疾病,每10 000名儿童的年发病率约为0.07至0.14。一名体重指数为48 kg / m 2 的15岁女性赞同口服避孕药,其临床表现与深静脉血栓形成以及肺栓塞一致。进一步的检查显示该患者的V因子Leiden是杂合的,而凝血酶原G20210A突变是纯合的。目前尚无针对具有多种VTE危险因素的患者进行抗血栓治疗的儿科指南。在成人VTE病例中涉及肥胖和使用含雌激素激素避孕药这两种危险因素,但在儿科患者中并未明确描述。鉴于儿童肥胖症的发生率和使用口服避孕药的青少年数量不断增加,对这些患者进行VTE治疗的指导需求变得更加明显。此外,尽管可能在无症状的一级亲属和患有抗凝血酶,蛋白C或蛋白S缺乏症的家庭中进行血栓形成检查,但仍存在争议。鉴于VTE的多种危险因素的发生率增加,还需要为VTE高风险的儿科患者开发一种全面的风险评估工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号